Clinical characterization of rare EGFR mutations in non-small cell lung cancer and in silico prediction of drug sensitivity

被引：0

作者：

Ikemura, S. ^{[1
]}

Yasuda, H. ^{[2
]}

Matsumoto, S. ^{[3
]}

Kamada, M. ^{[4
]}

Betsuyaku, T. ^{[2
]}

Okuno, Y. ^{[4
]}

Goto, K. ^{[5
]}

Tsuchihara, K. ^{[6
]}

Soejima, K. ^{[7
]}

机构：

[1] Keio Univ, Sch Med, Ctr Canc, Tokyo, Japan

[2] Keio Univ, Sch Med, Dept Pulm Med, Tokyo, Japan

[3] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[4] Kyoto Univ, Grad Sch Med, Kyoto, Japan

[5] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[6] Natl Canc Ctr, Div Translat Genom, Grp Translat Res, Tokyo, Japan

[7] Keio Univ Hosp, Translat Res Div, Clin & Translat Res Ctr, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1421P

引用

页码：513 / 513

页数：1

共 50 条

[1] Clinical characterization and in silico drug sensitivity prediction model of rare EGFR mutations in non-small cell lung cancer
Ikemura, Shinnosuke
Yasuda, Hiroyuki
Matsumoto, Shingo
Kamada, Mayumi
Hamamoto, Junko
Betsuyaku, Tomoko
Okuno, Yasushi
Goto, Koichi
Tsuchihara, Katsuya
Soejima, Kenzo
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] EGFR mutations in non-small cell lung cancer - Clinical implications
Charpidou, Andriani
Blatza, Despoina
Anagnostou, Elsa
Syrigos, Konstantinos N.
[J]. IN VIVO, 2008, 22 (04): : 529 - 536
[3] Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer
Eck, Michael J.
Yun, Cai-Hong
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03): : 559 - 566
[4] The incidence of rare and compound mutations of EGFR in non-small cell lung cancer and their potential clinical significance
Liang, Sharron
Wang, Bin
Chin, Venessa
Huang, Min
Wong, Stephen
Riley, Denise
Luo, Ruby
Barrett, Wade
Yang, Tao
Qiu, Min Ru
[J]. RESPIROLOGY, 2023, 28 : 28 - 29
[5] Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer
Hirsch, FR
Witta, S
[J]. CURRENT OPINION IN ONCOLOGY, 2005, 17 (02) : 118 - 122
[6] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR MUTATIONS IN NEVER SMOKERS
Park, Young Sik
Park, Ju-Hee
Lee, Jinwoo
Lee, Sang-Min
Lee, Chang-Hoon
Yim, Jae-Joon
Yoo, Chul-Gyu
Han, Sung Koo
Kim, Young Tae
Heo, Dae Seog
Kim, Young Whan
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1283 - S1283
[7] EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE
Rusu-Cordunean, F.
Berlea, Madalina Lavinia
Cernomaz, A. T.
Marinca, M. V.
Peter, Simona
Pavel, Ina
Grigoriu, B. D.
[J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2015, 119 (04): : 1031 - 1036
[8] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
Harrison, Peter T.
Vyse, Simon
Huang, Paul H.
[J]. SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
[9] The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancer
Karachaliou, Niki
Angel Molina-Vila, Miguel
Rosell, Rafael
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 241 - 244
[10] Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Gkolfinopoulos, Stavros
Mountzios, Giannis
[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)

← 1 2 3 4 5 →